Kraj: Izrael
Język: hebrajski
Źródło: Ministry of Health
FACTOR VIII (HUMAN)
MEDICI MEDICAL LTD, ISRAEL
B02BD03
אבקה להכנת תמיסה לזריקה
FACTOR VIII (HUMAN) 1500 IU/DOSE
תוך-ורידי
מרשם נדרש
INSTITUTO GRIFOLS S.A.,SPAIN,BARCELONA
FACTOR VIII INHIBITOR BYPASSING ACTIVITY
FACTOR VIII INHIBITOR BYPASSING ACTIVITY
Is indicated for the prevention and control of bleeding in patients with moderate or severe factor VIII deficiency due to classical hemophilia A . Fanhdi is not effective in controlling the bleeding of patients with Von Willebrond's disease.
2020-12-31